InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (8 ops.)
Explore the detailed record of transactions filed by Epperly Melissa B, Chief Financial Officer. Director active across 1 companies, notably Zentalis Pharmaceuticals, Inc.. Cumulatively, 13 reports have been logged. Total volume traded: €860k. The latest transaction was filed on 4 April 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations13 total
€359,4828,094 shares@ €44.41340.12% mcap12.7% of flow
Common Stock
SEC:0001725160-22-000069:0·
€52,1751,211 shares@ €43.08390.018% mcap1.8% of flow
Common Stock
SEC:0001725160-22-000047:0·
016,405 shares0
Common Stock
SEC:0001725160-22-000033:0·
€990,61117,080 shares@ €57.99830.34% mcap82.1% of flow
Common Stock
SEC:0001725160-21-000199·
€990,61117,080 shares@ €57.99830.34% mcap34.9% of flow
Common Stock
SEC:0001725160-21-000199:0·
€58,9131,326 shares@ €44.42940.020% mcap4.9% of flow
Common Stock
SEC:0001725160-21-000185·
Ideal exit: 15 May 2022 (T+270)
€58,9131,326 shares@ €44.42940.020% mcap2.1% of flow
Common Stock
SEC:0001725160-21-000185:0·
Ideal exit: 15 May 2022 (T+270)
€29,607700 shares@ €42.29550.010% mcap2.5% of flow
Common Stock
SEC:0001725160-21-000163·
€29,607700 shares@ €42.29550.010% mcap1.0% of flow
Common Stock
SEC:0001725160-21-000163:0·
€127,4052,883 shares@ €44.19190.044% mcap10.6% of flow
Common Stock
SEC:0001725160-21-000135·
€127,4052,883 shares@ €44.19190.044% mcap4.5% of flow
Common Stock
SEC:0001725160-21-000135:0·
350 shares
Common Stock
SEC:0001725160-21-000120·
€16,539350 shares@ €47.2540.0057% mcap0.6% of flow
Common Stock
SEC:0001725160-21-000120:0·
13 of 13 declarations
About Epperly Melissa B,
Melissa B. Epperly is the Chief Financial Officer at Zentalis Pharmaceuticals, Inc. In this role, she oversees financial operations and ensures compliance with regulations. With expertise in finance, she plays a crucial role in the financial management of the company.
